| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | Director | Common Stock | 0 | $20.00 | 02 Mar 2023 | Direct | |
| OPIANT PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 0 | $10.00 | 02 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000138550823000061-macdougall-ann-l-2023-03-02 | OPIANT PHARMACEUTICALS, INC. | 02 Mar 2023 | 6 | -$563,580 | 4 | Director | 03 Mar 2023, 08:08 |
| /report/000138550822000084-macdougall-ann-l-2022-06-14 | OPIANT PHARMACEUTICALS, INC. | 14 Jun 2022 | 1 | $0 | 4 | Director | 14 Jun 2022, 16:53 |
| /report/000138550822000057-macdougall-ann-l-2022-05-13 | OPIANT PHARMACEUTICALS, INC. | 13 May 2022 | 1 | +$32,778 | 4 | Director | 16 May 2022, 16:03 |
| /report/000138550821000086-macdougall-ann-l-2021-06-15 | OPIANT PHARMACEUTICALS, INC. | 15 Jun 2021 | 2 | $0 | 4 | Director | 16 Jun 2021, 16:06 |
| /report/000138550821000070-macdougall-ann-l-2021-05-13 | OPIANT PHARMACEUTICALS, INC. | 13 May 2021 | 2 | $0 | 4 | Director | 13 May 2021, 16:06 |